## RKLB: Rocket Lab Corporation - XLI: Industrials

### Executive Summary

PARABOLIC warning: MRS_20 at 46.2% exceeds exhaustion threshold (10.0%). Extreme momentum typically precedes mean reversion. Consider profit-taking or tight stops.

- **Horizon:** 1-5 days (momentum)
- **Risk Profile:** High - extreme momentum reversal risk
- **Stop Type:** Fixed 2xATR ($67.17)
- **If Wrong:** Exit on momentum reversal or stop hit
- **Invalidation:** MRS_20 drops below exhaustion threshold

### News

- **Articles:** 4
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Rocket Lab Successfully Launches for iQPS, Ends 2025 with 21 Launches and 100% Mission Success**
- Source: GlobeNewswire | 20251221T140906 | Bullish | Relevance: 100%
- Rocket Lab has successfully completed its 21st Electron rocket launch of the year for iQPS, a Japan-based Earth imaging company, deploying the QPS-SAR-15 satellite. This mission, named ‘The Wisdom God Guides,’ marks a new annual launch record for Electron with a 100% mission success rate, solidifying its position as a leading small launch provider. Rocket Lab plans further launches for iQPS and anticipates expanding Electron's global reach in 2026 for various civil, international, and defense applications.

**2. Rocket Lab Stock (RKLB) Surges After $816M Space Force Satellite Contract — News, Forecasts and Analyst Outlook for Dec. 20, 2025**
- Source: ts2.tech | 20251221T030921 | Bullish | Relevance: 100%
- Rocket Lab's (RKLB) stock surged after securing an $816 million contract from the Space Development Agency (SDA) for 18 missile-tracking satellites, boosting its defense business and long-term revenue visibility. This win, combined with robust launch cadence and anticipation for its Neutron rocket in 2026, positions Rocket Lab for further growth, though analysts note potential volatility and the lagging nature of some price targets. Investors are closely watching for updates on the TRKT3 program and Neutron’s development.

**3. Rocket Lab Stock After Hours (RKLB): $816M Space Force Satellite Deal Fuels a Friday Surge — What to Know Before the Next Market Open**
- Source: ts2.tech | 20251220T010902 | Bullish | Relevance: 100%
- Rocket Lab (RKLB) experienced a significant surge following the announcement of an $816 million prime contract with the U.S. Space Development Agency to design and manufacture 18 satellites for missile warning and tracking. This deal solidifies Rocket Lab's position as a prime contractor, moving beyond its traditional role as a launch services provider. Investors are now focused on several factors, including the contract's long-term implications, execution risks, and whether the after-hours gains will hold when the markets reopen on Monday.

**4. Rocket Lab (RKLB) Stock: Space Force Satellite Deal, Record Electron Launches, Neutron Timeline, and Wall Street Forecasts Ahead of the Dec. 22, 2025 Market Open**
- Source: ts2.tech | 20251222T040906 | Bullish | Relevance: 100%
- Rocket Lab (RKLB) is gaining investor attention due to several recent developments, including a significant $816 million contract award from the U.S. Space Development Agency for missile warning satellites. The company also achieved a record 21 Electron launches in 2025 with 100% mission success, while investors closely monitor progress on its reusable medium-lift rocket, Neutron, targeted for a 2026 debut. Despite bullish analyst ratings, the company's valuation remains a point of discussion, especially given its current unprofitability during a heavy investment phase.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | Stifel | $85 | $75 | +13% |
| 2025-11-25 | Needham | $63 | $63 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | Stifel | main | Buy |
| 2025-11-25 | Needham | reit | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 12 ($27.76M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 29.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 7.8% (+5.4%)
- Blackrock Inc.: 5.9% (+38.0%)
- Capital World Invest: 2.7% (+9.4%)
- State Street Corpora: 2.3% (+13.6%)
- BAILLIE GIFFORD & CO: 2.3% (+176.1%)

### Key Risks

1. High beta (2.21) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Heavy insider selling: $28M sold (12 transactions in 90 days).
3. Elevated short interest (9.6%): bears positioning against stock.

### Catalysts

- Momentum building: MRS_20 improving +30.2% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.45 suggests fair value with growth premium. Balance sheet: strong liquidity (3.2x). Revenue growth strong at 47% YoY. Analyst sentiment positive (1 raises, avg +13%). Insider selling cluster ($27.8M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $41.4B |
| Beta | 2.21 |
| 52W Range | $14.71 - $78.44 |
| Short Interest | 9.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.45 |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_20 strengthening from 16.0% to 46.2% (+30.2% in 5 days), confirming momentum buildup. Extended beyond STRENGTH zone (46.2% > 10.0%), caution on chasing. MRS_5 at 20.6% confirms short-term momentum alignment. AM_20 at 47.0% shows strong absolute momentum above own 20MA. Outperforming sector by 45.1pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (2.74), confirming momentum. RSI overbought at 75, risk of mean reversion. Elevated volume (1.9x 20MA), institutional activity likely. OFD pattern: +MTH (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 46.20% (CS: 100) | Strong |
| RSI_14 | 74.7 | Overbought |
| MACD Histogram | 2.74 | Bullish |
| vs SMA20 | 1.470x | Above |
| vs SMA50 | 1.405x | Above |
| vs SMA200 | 1.951x | Above |

### Decision

- **Verdict:** SELL
- **Thesis:** PARABOLIC

### Trade Setup

- **Entry:** $77.55
- **Stop Loss:** $67.17 (13.4% risk)
- **Target:** $87.93 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** PARABOLIC thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 86
- **Position Value:** $6,669.30
- **Portfolio %:** 6.67%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-26 (Est: $-0.10)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.10 | $-0.03 | +71.3% |
| 2025Q2 | $-0.11 | $-0.13 | -17.9% |
| 2025Q1 | $-0.12 | $-0.12 | +0.5% |
| 2024Q4 | $-0.10 | $-0.10 | -2.2% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*